tiprankstipranks
Trending News
More News >
INNOVATE Corp (VATE)
NYSE:VATE
Advertisement

INNOVATE Corp (VATE) AI Stock Analysis

Compare
266 Followers

Top Page

VATE

INNOVATE Corp

(NYSE:VATE)

Rating:45Neutral
Price Target:
$5.00
▼(-5.84% Downside)
The overall stock score of 45 reflects significant financial challenges and valuation concerns, which are partially offset by some positive technical indicators and strategic progress highlighted in the earnings call. The company's high leverage and ongoing losses are the most significant factors impacting the score.

INNOVATE Corp (VATE) vs. SPDR S&P 500 ETF (SPY)

INNOVATE Corp Business Overview & Revenue Model

Company DescriptionINNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. It provides industrial construction, structural steel, and facility maintenance services for use in commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants. The company also fabricates trusses and girders; and fabricates and erects water pipe, water storage tanks, tunnel liners, pressure vessels, strainers, filters, separators, and other customized products. In addition, it offers integrated solutions for digital engineering, modeling and detailing, construction, heavy equipment installation, and facility services; and steel and rebar detailing, and BIM modeling and management services, as well as equipment used in the oil, gas, petrochemical, and pipeline industries. Further, the company develops products for early osteoarthritis of the knee, and aesthetic and medical technologies for the skin. Additionally, it operates over-the-air broadcasting stations and Azteca America, a Spanish-language broadcast network. The company was formerly known as HC2 Holdings, Inc. and changed its name to INNOVATE Corp. in September 2021. The company was incorporated in 1994 and is headquartered in New York, New York.
How the Company Makes MoneyINNOVATE Corp generates revenue through multiple streams, primarily by offering subscription-based software services and licensing fees for its proprietary technologies. The company also earns money from consulting services, where it partners with businesses to implement customized tech solutions. Additionally, VATE has established strategic alliances with key players in the tech industry, enabling them to create bundled service offerings that enhance their market reach and drive higher sales volumes. The growing demand for cloud computing and AI solutions further contributes to its earnings, as more businesses seek to adopt these technologies for improved productivity and competitiveness.

INNOVATE Corp Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed performance for INNOVATE. While significant strides were made in increasing backlog and achieving growth in the Life Sciences segment and R2, the company faced notable challenges with a substantial decrease in consolidated revenue and a net loss for the quarter. The successful debt refinancing is a positive development, but the overall financial performance indicates ongoing challenges.
Q2-2025 Updates
Positive Updates
Increase in DBM Global Backlog
DBM Global's adjusted backlog increased year-over-year by approximately $300 million to just over $1.3 billion, with an additional $400 million project expected to be added in the third quarter.
R2 Growth and Expansion
R2 reported strong growth with revenues increasing to $3.2 million from $1.7 million year-over-year. Notable achievements include a 115.1% increase in patient treatments, a 28.5% increase in average monthly utilization per provider, and significant growth in social media engagements, mentions, and web users.
Life Sciences Revenue Increase
The Life Sciences segment saw an 88.2% increase in revenue to $3.2 million, primarily driven by R2's growth in Glacial Spa unit sales, consumable sales, and international expansion.
Successful Debt Refinancing
INNOVATE successfully announced the early settlement of refinancing transactions, allowing for the extension of debt maturities and continuing pursuit of strategic plans.
Negative Updates
Decrease in Consolidated Revenue
Consolidated revenue for the second quarter of 2025 was $242 million, a decrease of 22.7% compared to the prior year period.
Net Loss for the Quarter
INNOVATE reported a net loss attributable to common stockholders of $22 million compared to net income of $14.1 million in the prior year period.
Infrastructure Segment Revenue Decline
Infrastructure segment revenue decreased by 23.6% to $233.1 million, primarily due to the timing and size of projects.
Spectrum Segment Revenue Decline
Spectrum segment experienced a year-over-year revenue decrease of $500,000 to $5.7 million, mainly due to the loss of certain customers and a decrease in direct response advertising.
Company Guidance
During the second quarter of 2025, INNOVATE Corp. reported consolidated revenues of $242 million, a decrease of 22.7% from the previous year, and an adjusted EBITDA of $15.7 million, down from $26.7 million. The Infrastructure segment saw a revenue decline of 23.6% to $233.1 million, with adjusted EBITDA reducing to $19.3 million, influenced by project timings and reduced margins. Life Sciences, however, showed an 88.2% increase in revenue to $3.2 million, driven by R2's sales, while Spectrum's revenue decreased by $500,000 to $5.7 million. Despite a net loss of $22 million, INNOVATE showed strategic progress, including a refinancing initiative to extend debt maturities, a robust backlog increase to over $1.3 billion, and ongoing pipeline optimism across segments.

INNOVATE Corp Financial Statement Overview

Summary
INNOVATE Corp faces significant financial challenges, with declining revenues, persistent losses, and high leverage. While there are some positive aspects, such as stable gross profit margins and positive cash flow ratios, the overall financial health is concerning. The company needs to address operational inefficiencies and reduce reliance on debt to improve its financial position and ensure long-term sustainability.
Income Statement
45
Neutral
INNOVATE Corp's income statement reveals challenges with profitability and revenue growth. The TTM data shows a negative net profit margin of -3.91% and a declining revenue growth rate of -6.67%. Gross profit margin remains relatively stable at 18.88%, but the company struggles with negative EBIT and EBITDA margins, indicating operational inefficiencies. The overall trend shows declining revenues and persistent losses, which are concerning for future profitability.
Balance Sheet
30
Negative
The balance sheet highlights significant financial leverage with a high debt-to-equity ratio of 33.99 in the TTM period. The company's equity is minimal, posing a risk of financial instability. Return on equity is positive at 37.49%, but this is due to the low equity base rather than strong performance. The equity ratio is weak, indicating heavy reliance on debt financing, which could be risky in volatile market conditions.
Cash Flow
50
Neutral
Cash flow analysis shows mixed results. Operating cash flow is positive, but free cash flow growth is negative at -8.70% in the TTM period. The operating cash flow to net income ratio is low, suggesting limited cash generation relative to net losses. However, the free cash flow to net income ratio is positive, indicating some ability to cover net losses with free cash flow. Overall, cash flow management needs improvement to support financial stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue995.00M1.11B1.42B1.64B1.21B1.01B
Gross Profit185.70M208.80M216.00M221.40M183.70M167.30M
EBITDA50.40M-99.00M69.80M53.10M16.00M54.90M
Net Income-75.90M-35.80M-37.60M-40.80M-79.80M-46.40M
Balance Sheet
Total Assets890.90M891.10M1.04B1.15B1.08B6.74B
Cash, Cash Equivalents and Short-Term Investments33.40M48.80M80.80M80.40M45.50M4.69B
Total Debt689.90M719.20M771.90M714.40M626.30M561.50M
Total Liabilities1.10B1.03B1.18B1.18B1.07B6.14B
Stockholders Equity-224.80M-180.40M-149.10M-103.70M-65.50M559.80M
Cash Flow
Free Cash Flow2.10M-9.90M8.10M-30.20M2.90M23.90M
Operating Cash Flow23.10M9.10M26.50M-9.50M27.00M41.70M
Investing Cash Flow71.80M-13.90M39.10M-22.50M-223.20M162.30M
Financing Cash Flow-162.80M-26.50M-65.30M68.10M4.30M-204.60M

INNOVATE Corp Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.31
Price Trends
50DMA
5.28
Positive
100DMA
5.67
Negative
200DMA
6.63
Negative
Market Momentum
MACD
-0.12
Negative
RSI
53.88
Neutral
STOCH
77.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VATE, the sentiment is Positive. The current price of 5.31 is above the 20-day moving average (MA) of 4.99, above the 50-day MA of 5.28, and below the 200-day MA of 6.63, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 53.88 is Neutral, neither overbought nor oversold. The STOCH value of 77.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VATE.

INNOVATE Corp Risk Analysis

INNOVATE Corp disclosed 83 risk factors in its most recent earnings report. INNOVATE Corp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

INNOVATE Corp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$4.01B24.1933.00%21.87%18.56%
70
Outperform
$173.67M60.895.24%0.58%9.52%-88.22%
65
Neutral
$285.70M25.517.90%15.85%
64
Neutral
$10.95B16.378.81%1.96%2.68%-15.33%
46
Neutral
$117.81M-679.42%-0.77%30.69%
45
Neutral
$66.68M17.11%-27.08%-115.05%
43
Neutral
$221.86M-41.62%-23.35%-49.27%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VATE
INNOVATE Corp
5.31
1.18
28.57%
ESOA
Energy Services of America
10.36
0.96
10.21%
ORN
Orion Group Holdings
7.23
-0.38
-4.99%
SLND
Southland Holdings
4.03
-0.21
-4.95%
SHIM
Shimmick Corporation
3.29
0.44
15.44%
ECG
Everus Construction Group, Inc.
77.33
27.33
54.66%

INNOVATE Corp Corporate Events

Business Operations and StrategyFinancial Disclosures
INNOVATE Corp Reports Q2 2025 Revenue Decline
Negative
Aug 5, 2025

INNOVATE Corp announced its second quarter 2025 results, highlighting a decrease in consolidated revenue by 22.7% compared to the previous year, primarily due to declines in the Infrastructure and Spectrum segments. Despite the revenue drop, the company emphasized its strategic refinancing transactions that extend debt maturities, and noted growth in its Life Sciences segment, particularly with the FDA-approved MediBeacon system and R2’s increased sales. The company is also exploring new datacasting opportunities in its Spectrum segment, aiming for improved performance in the latter half of the year.

Private Placements and FinancingBusiness Operations and Strategy
INNOVATE Corp Completes Debt Refinancing Transactions
Positive
Aug 5, 2025

On August 4, 2025, INNOVATE Corp completed a series of refinancing transactions to extend the maturities of 81.7% of its outstanding debt as of June 30, 2025. This strategic move includes the exchange of senior secured notes, convertible notes, and amendments to various credit agreements, which is expected to enhance the company’s financial flexibility and potentially improve its market positioning.

Private Placements and FinancingBusiness Operations and Strategy
INNOVATE Corp Announces Successful Exchange Offer Results
Positive
Jul 31, 2025

INNOVATE Corp. announced early results of its exchange offer for its 8.5% Senior Secured Notes due 2026, with a successful tender of 99.41% of the notes, meeting the minimum exchange condition. The company will extend eligibility for the Total Early Exchange Consideration until the expiration deadline, with early settlement expected on August 4, 2025, and final settlement on August 15, 2025. This move aims to enhance the company’s financial structure by exchanging notes for newly issued 10.5% Senior Secured Notes due 2027, which include updated covenants and an increased interest rate.

Dividends
INNOVATE Corp Announces Dividend from DBM Global
Positive
Jul 28, 2025

On July 28, 2025, INNOVATE Corp. announced that its subsidiary, DBM Global Inc., will distribute a cash dividend of approximately $4.4 million, or $1.14 per share, to its stockholders on August 21, 2025. As the largest stockholder, INNOVATE expects to receive around $4 million of this payout, highlighting its significant stake in DBM Global and the financial benefits accruing from this investment.

Private Placements and FinancingBusiness Operations and Strategy
INNOVATE Corp Announces Debt Refinancing Plans
Positive
Jul 17, 2025

On July 17, 2025, INNOVATE Corp. announced plans to refinance its debt through a series of transactions, including exchanging convertible senior notes and senior secured notes, extending its revolving credit agreement, and amending other financial agreements. These actions aim to extend debt maturities and improve financial flexibility, potentially enhancing the company’s market position and stability.

Executive/Board ChangesShareholder Meetings
INNOVATE Corp Annual Meeting Decisions Announced
Neutral
Jun 12, 2025

INNOVATE Corp held its Annual Meeting of Stockholders on June 12, 2025, where key decisions were made regarding the company’s governance and executive compensation. Stockholders elected four directors to the board, approved the compensation of executive officers, decided to hold annual Say on Pay Votes, and ratified the appointment of BDO USA, P.C. as the independent accounting firm for the fiscal year ending December 31, 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2025